Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder.
doi: 10.1371/journal.pone.0134572. eCollection 2015. Brunner D., Kabitzke P., He D., Cox K., Thiede L., Hanania T., He D., Sabath E., Alexandrov...
Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington’s disease: zQ175
Menalled L, Kudwa A, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio B, McConnell K,...
Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegeneration,
Brunner, D., Balci, F., and Ludvig, E. A. Behav Processes 2011 89, 187-195
Rapid, computer vision-enabled murine screening system identifies neuropharmacological potential of two new mechanisms.
Steven L Roberts, Filippov I.; Alexandrov V.; Hanania T.; Brunner D. Frontiers in Neuropharmacology.
Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone.
Paterson, N. E.; Ricciardi, J.; Wetzler, C.; Hanania, T. Neurosci Res 2011, 69, 41-50.
Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats.
Kehr, J.; Ichinose, F.; Yoshitake, S.; Goiny, M.; Sievertsson, T.; Nyberg, F.; Yoshitake, T. Br J Pharmacol
Comprehensive behavioral testing in the R6/2 mouse model of Huntington’s disease shows no benefit from CoQ10 or minocycline.
Menalled, L. B.; Patry, M.; Ragland, N.; Lowden, P. A.; Goodman, J.; Minnich, J.; Zahasky, B.; Park, L.; Leeds, J.;...
Comparison of Three Novel Neuroprotective Therapies for Traumatic Brain Injury Using a CCIModel in Rats
Johana Bastidas, Michael Lang, Rachel Barrett, Smriti Mongia, Daniel Havas, Taleen Hanania. Traumatic brain injury (TBI) is a major cause...